LUIS GONZAGA
PAZ-ARES RODRÍGUEZ
Profesor titular de universidad
![Foto de LUIS GONZAGA](/img/nophoto.png)
![Foto de Universitat de València](/img/noimage_org.png)
Universitat de València
Valencia, EspañaPublications in collaboration with researchers from Universitat de València (8)
2023
-
Signature-driven repurposing of Midostaurin for combination with MEK1/2 and KRASG12C inhibitors in lung cancer
Nature Communications, Vol. 14, Núm. 1
2018
-
Impact of DLK1-DIO3 imprinted cluster hypomethylation in smoker patients with lung cancer
Oncotarget, Vol. 9, Núm. 4, pp. 4395-4410
2016
-
Analysis of the immune microenvironment in resected non-small cell lung cancer: The prognostic value of different T lymphocyte markers
Oncotarget, Vol. 7, Núm. 33, pp. 52849-52861
2014
-
Open-label, multicentre expansion cohort to evaluate imgatuzumab in pre-treated patients with KRAS-mutant advanced colorectal carcinoma
European Journal of Cancer, Vol. 50, Núm. 3, pp. 496-505
-
Social value of a quality-adjusted life year (QALY) in Spain: the point of view of oncologists
Clinical and Translational Oncology, Vol. 16, Núm. 10, pp. 914-920
2013
-
First-in-humans trial of an RNA interference therapeutic targeting VEGF and KSP in cancer patients with liver involvement
Cancer Discovery, Vol. 3, Núm. 4, pp. 406-417
2011
-
Phase I pharmacokinetic and pharmacodynamic dose-escalation study of RG7160 (GA201), the first glycoengineered monoclonal antibody against the epidermal growth factor receptor,,in patients with advanced solid tumors
Journal of Clinical Oncology, Vol. 29, Núm. 28, pp. 3783-3790
2002
-
Pemetrexed in bladder, head and neck, and cervical cancers
Seminars in Oncology, Vol. 29, Núm. 6 SUPPL. 18, pp. 69-75